Program
BWC0977
A development code.
Its studies are mostly in Communicable Diseases, led by Bugworks Research.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bugworks Research | 31 open or running | phase 1since Sep 9, 2021 | Sep 9, 2021 | Jun 30, 2027phase 1 · NCT07029932 |
Also a collaborator on its studies: avance-clinical-pty-ltd.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 9, 2021First study: phase 1 study in Communicable DiseasesFirst studyNCT05088421 · 44 enrolled · Australia
- Jul 5, 2023Phase 1 study in Communicable DiseasesNCT05942820 · 4 enrolled · Australia
- Jun 12, 2025Phase 1 study in Communicable DiseasesNCT07029932 · 48 planned · Australia
Ahead
- Jun 30, 2027Primary completion: phase 1 study in Communicable DiseasesNCT07029932
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07029932Communicable Diseases · Australia | 1 | Recruiting | Jun 30, 2027 | 48 |
| NCT05942820Communicable Diseases · Australia | 1 | Terminated | Jan 30, 2024 | 4 |
| NCT05088421Communicable Diseases · Australia | 1 | Completed | Dec 29, 2022 | 44 |
How it is read
Names in the registry
- “BWC0977”, 3 entries
Codes read as this program: BWC0977.
Conditions, from the studies’ own filings
- Communicable Diseases, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.